Thursday, 22 March 2018: POSTER SESSION: Systemic Treatment: Poster338 (PB-133) - Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer
References (0)
Cited by (0)
Copyright © 2018 Elsevier Ltd. All rights reserved.